European Reference Laboratory Network for TB (ERLTB-Net)
The ERLTB-Net sub-network of reference laboratories from EU/EEA Member States supports harmonisation of methods and laboratory capacity for tuberculosis diagnosis, antimicrobial susceptibility testing and typing in the EU/EEA.
Antimicrobial resistance - Tuberculosis
In EU, only 1 in every 3 MDR TB patients has a successful treatment outcome; more than half either die, fail treatment or default (stop taking treatment). XDR TB has even worse treatment outcomes: only 1 in 4 patients finishes treatment successfully.
Development of a standardised tool to survey MDR-/XDR-TB case management in Europe
Sotgiu, G., Centis, R., D'Ambrosio, L., de Lorenzo, S., D'Arcy Richardson, M., Lange, C., Manissero, D., Migliori, G.B.
Molecular epidemiological typing within the European Gonococcal Antimicrobial Resistance Surveillance Programme reveals predominance of a multidrugresistant clone
Chisholm, S.A., Unemo, M., Quaye, N., Johansson, E., Cole, M.J., Ison, C.A., van der Laar, M.J.W.